Zai Lab Limited (ZLAB)

Analyzing Zai Lab (NASDAQ:ZLAB) and Cytokinetics (NASDAQ:CYTK)

Zai Lab (NASDAQ:ZLAB) Shares Climb 3.8% – Here’s Why

Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Z.ai shares surge 8% after releasing new AI model running only on Chinese chips

Zai Lab: Revenue Growth And Zoci's Upside Optionality

Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

Zai Lab Q2 Earnings Call Highlights

Zai Lab Limited (ZLAB) Q2 2026 Earnings Call Transcript

Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings

Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of “Moderate Buy” from Analysts

U.S. FDA Grants Orphan Drug Designation to Zai Lab's DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs)

Viridian Therapeutics (NASDAQ:VRDN) and Zai Lab (NASDAQ:ZLAB) Financial Review

Zai Lab to Announce Second Quarter 2026 Financial Results and Recent Corporate Updates on August 6, 2026